The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma

The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common pediatric soft-tissue cancer with a survival rate below 27% for high-risk children despite aggressive multi-modal therapeutic interventions. After decades of research, no targeted therapies are currently available. Therapeutically targeting actin-binding pro...

Full description

Bibliographic Details
Main Authors: Robert Cornelison, Laine Marrah, Adelaide Fierti, Claire Piczak, Martyna Glowczyk, Anam Tajammal, Sarah Lynch, Hui Li
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
rhabdomyosarcoma
pediatric cancer
actin-binding protein
advillin
AVIL
Online Access:https://www.mdpi.com/1422-0067/24/18/14196

Similar Items

Similar Items